These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2331334)

  • 1. Structure of (R)-tetrahydro-2-furancarboxylic acid monohydrate.
    Bando S; Takano T; Tanaka R; Iwata H; Ishiguro M
    Acta Crystallogr C; 1990 Jan; 46 ( Pt 1)():106-8. PubMed ID: 2331334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of histamine H1-receptor antagonists derived from the cimetidine group of histamine H2-receptor antagonists.
    Bannister C; Burns K; Prout K; Watkin DJ; Cooper DG; Duránt GJ; Ganellin CR; Ife RJ; Sach GS
    Acta Crystallogr B; 1994 Apr; 50 ( Pt 2)():221-43. PubMed ID: 7911673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural comparison of a gem-dichlorodiarylcyclopropane antiestrogen and three of its derivatives.
    Hossain MB; Wang JL; van der Helm D; Magarian RA; Griffin MT; Day BW
    Acta Crystallogr B; 1991 Aug; 47 ( Pt 4)():511-21. PubMed ID: 1930832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of N-gamma-L-glutamyl-L-cysteine ethyl ester monohydrate.
    Takimoto-Kamimura M; Koyano K; Kitahara S; Fujii K
    Acta Crystallogr C; 1990 Nov; 46 ( Pt 11)():2247-9. PubMed ID: 2073376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of quinoxaline antibiotics.
    Sheldrick GM; Heine A; Schmidt-Bäse K; Pohl E; Jones PG; Paulus E; Waring MJ
    Acta Crystallogr B; 1995 Dec; 51 ( Pt 6)():987-99. PubMed ID: 8554726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activating factor antagonist design: structure of methyl trans-5-(3,4-dimethoxyphenyl)-2,3,4,5-tetrahydro-2-oxo-4- furancarboxylate.
    Peterson JR; Smillie TJ; Rogers RD
    Acta Crystallogr C; 1989 Feb; 45 ( Pt 2)():297-300. PubMed ID: 2610971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activating factor antagonist design. 2. X-ray structure of dimethyl 2,3,4,5-tetrahydro-5 beta-(3,4-methylenedioxyphenyl)-2-oxo-3 beta-(3,4,5-trimethoxybenzoyl)-3 alpha,4 alpha-furandicarboxylate.
    Peterson JR; Do HD; Rogers RD
    Acta Crystallogr C; 1989 Jul; 45 ( Pt 7)():1059-63. PubMed ID: 2610989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of 5 beta-pregnane-3 alpha, 6 alpha, 17 alpha-triol triacetate.
    Grochulski P; Wawrzak Z; Gałdecki Z; Duax WL; Strong PD
    Acta Crystallogr C; 1992 Dec; 48 ( Pt 12)():2247-9. PubMed ID: 1292514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of N-acetylbenzamide, N-propionylbenzamide and N-butyrylbenzamide and analysis of imide hydrogen-bond patterns.
    Etter MC; Britton D; Reutzel SM
    Acta Crystallogr C; 1991 Mar; 47 ( Pt 3)():556-61. PubMed ID: 2069767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural study of aldose reductase inhibitors. Ten oxazolecarbamate derivatives.
    Ishida T; In Y; Tanaka C; Inoue M
    Acta Crystallogr B; 1991 Oct; 47 ( Pt 5)():806-13. PubMed ID: 1793545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structures of chloro(glycinato)(1,10-phenanthroline)copper(II) monohydrate (I) and aqua(1,10-phenanthroline)(L-phenylalaninato)copper(II) nitrate monohydrate (II).
    Solans X; Ruiz-Ramírez L; Martinez A; Gasque L; Briansó JL
    Acta Crystallogr C; 1988 Apr; 44 ( Pt 4)():628-31. PubMed ID: 3271071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of N-acetyl-L-leucyl-L-prolinamide monohydrate.
    Puliti R; Mattia CA; Lilley TH
    Acta Crystallogr C; 1992 Apr; 48 ( Pt 4)():709-12. PubMed ID: 1515104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of (2'R*,5S*)-(+/-)-5-(tetrahydro-2'H-pyran-2'-yl)-2(5H)-furanone.
    Ammon HL; DeShong P; Lessen TA
    Acta Crystallogr C; 1991 Nov; 47 ( Pt 11)():2488-9. PubMed ID: 1805871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activating factor antagonist design. 3. X-ray crystal structure and intermolecular crystal lattice interactions of methyl trans-4-acetoxymethyl-4,5-dihydro-2,5-bis(3,4-methylenedioxyphenyl)- 3-furancarboxylate.
    Peterson JR; Horsley DB; Brozik JA; Rogers RD
    Acta Crystallogr C; 1989 Aug; 45 ( Pt 8)():1164-7. PubMed ID: 2604943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural study of histamine H2-receptor antagonists. Five 3-[2-(diamino-methyleneamino)-4-thiazolylmethylthio]propionamidine and -amide derivatives.
    Ishida T; In Y; Doi M; Inoue M; Yanagisawa I
    Acta Crystallogr B; 1989 Oct; 45 ( Pt 5)():505-12. PubMed ID: 2574586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of methyl 5-phenyl-2-propionyl-3-pyrrolecarboxylate.
    Nethaji M; Pattabhi V; Thailambal VG
    Acta Crystallogr C; 1989 Oct; 45 ( Pt 10)():1571-3. PubMed ID: 2610958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure of new bronchospasmolytic agents. I.
    Ianelli S; Nardelli M; Belletti D; Jamart-Gregoire B; Mouaddib A; Caubere P
    Acta Crystallogr B; 1992 Apr; 48 ( Pt 2)():178-85. PubMed ID: 1515105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of tris(pentafluorophenyl)phosphine.
    Karipides A; Cosio CM
    Acta Crystallogr C; 1989 Nov; 45 ( Pt 11)():1743-5. PubMed ID: 2610962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and absolute configuration of (E)-(-)-2-cyclododecenyl camphanate.
    Ito S; Ziffer H; Silverton JV
    Acta Crystallogr C; 1989 Mar; 45 ( Pt 3)():515-8. PubMed ID: 2610976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of WF-3681, 3-(2,5-dihydro-4-hydroxy-5-oxo-3-phenyl-2-furyl)propionic acid.
    Kissinger CR; Turley S; Clark JI
    Acta Crystallogr C; 1988 Mar; 44 ( Pt 3)():512-4. PubMed ID: 3152105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.